<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03918889</url>
  </required_header>
  <id_info>
    <org_study_id>2013005</org_study_id>
    <nct_id>NCT03918889</nct_id>
  </id_info>
  <brief_title>Effect of Dexmedetomidine in Preventing Cough and Postoperative Pain After Laryngeal Surgery for Cancer</brief_title>
  <official_title>A Randomized Controlled Trial of the Effect of Dexmedetomidine Compared With Midazolam on Airway Reflex and Recovery Quality During Emergence From General Anesthesia After Partial and Total Laryngectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye &amp; ENT Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye &amp; ENT Hospital of Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: During emergence from anesthesia for partial and total laryngectomy, severe
      airway reflex and systemic hypertension during recovery may lead to pneumoderm, hemorrhage,
      pneumomediastinum or pneumothorax. Dexmedetomidine is a selective α2-adrenoreceptor agonist
      that has sedative, analgesic, and sympatholytic properties. It has been reported
      dexmedetomidine can attenuate coughing reflex and prevent emergence agitation without
      delaying recovery and respiratory depression from general anesthesia. The purpose of this
      study was to investigate the effect of dexmedetomidine compared with midazolam on cough
      suppression and recovery quality during emergence from general anesthesia after partial and
      total laryngectomy.

      Methods American Society of Anesthesiologists physical status I-II male adults undergoing
      elective laryngectomy under sevoflurane anesthesia were recruiting and randomly allocated to
      receive either dexmedetomidine(Group D, n = 60) infusion at 0.5 µg•kg−1 for 10 min before
      tracheotomy, then adjusted to 0.3µg•kg−1•h−1 or midazolam (Group M, n = 60) infusion at 0.05
      mg•kg−1 ten minutes before tracheotomy, then adjusted to 0.02mg•kg−1•h−1. The primary outcome
      measure was the incidence and severity of cough. Hemodynamics, pain intensity [Visual
      Analogue Scale (VAS)] and Ramsay sedation scale (RSS) were also evaluated at awake, patients
      returning to ward from post anesthesia care unit (PACU),2h after surgery. postoperative
      sufentanil consumption, recovery time and the incidence of concerning adverse effects were
      recorded.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The severity of cough</measure>
    <time_frame>Time0:2hours after surgery</time_frame>
    <description>Coughing severity was classified using the 3-point scale.:1=mild (single) cough, 2=moderate (≤5 s) cough, and 3=severe (&gt;5 s) cough.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time0: 0 minute after arriving the operation room</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time0: 0 minute after arriving the operation room</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time0: 0 minute after arriving the operation room</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time0: 0 minute after arriving the operation room</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time1:0 minute after drug administration</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time1:0 minute after drug administration</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time1:0 minute after drug administration</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time1:0 minute after drug administration</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time2:0 minute after intubation</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time2:0 minute after intubation</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time2:0 minute after intubation</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time2:0 minute after intubation</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time3:0 minute after medicine intervention</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time3:0 minute after medicine intervention</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time3:0 minute after medicine intervention</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time3:0 minute after medicine intervention</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time4:0 minute after laryngectomy</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time4:0 minute after laryngectomy</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time4:0 minute after laryngectomy</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time4:0 minute after laryngectomy</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time5:0 minute after the completion of surgery</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time5:0 minute after the completion of surgery</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time5:0 minute after the completion of surgery</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time5:0 minute after the completion of surgery</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time6:0 minute after awareness</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time6:0 minute after awareness</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>Time6:0 minute after awareness</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time6:0 minute after awareness</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>Time7:0 minute after departure from the PACU</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>Time7:0 minute after departure from the PACU</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BDP</measure>
    <time_frame>Time7:0 minute after departure from the PACU</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Time7:0 minute after departure from the PACU</time_frame>
    <description>Oxygen saturation using pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>Time0:2hours after surgery</time_frame>
    <description>Assessed by Visual Analogue Scale (VAS), (0, no pain; 10, the worst pain intolerable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>Time0: 2hours after surgery</time_frame>
    <description>Assessed by Ramsay sedation scale (RSS),1, Anxious or restless or both,2, Cooperative, orientated and tranquil,3,Responding to commands,4,Brisk response to stimulus,5,Sluggish response to stimulus,6, No response to stimulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of adverse effects</measure>
    <time_frame>Time0:2hours after surgery</time_frame>
    <description>desaturation,shivering,drowsiness, delirium,hypertension,hypotension,itching,arrhythmia,respiratory depression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Laryngectomy; Status</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receive dexmedetomidine infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receive midazolam infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine Injectable Product</intervention_name>
    <description>dexmedetomidine infusion at 0.5 µg•kg−1 for 10 min before tracheotomy then adjusted to 0.3µg•kg−1•h−1</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam injection</intervention_name>
    <description>midazolam infusion at 0.05 mg•kg−1 ten minutes before tracheotomy then adjusted to 0.02mg•kg−1•h−1</description>
    <arm_group_label>midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subject scheduled for partial or total laryngectomy.

        Exclusion Criteria:

        Subject has respiratory disease; Subject has pharyngeal paraganglioma; Subject has cardiac
        disease; Uncontrolled hypertension; Subject has been taking β-adrenoreceptor blockers;
        Long-term abuse of alcohol (&gt;6 months),opioids, or sedative—hypnotic drugs; Allergic to
        dexmedetomidine or midazolam; Subject has neuropsychiatric diseases; Operation time shorter
        than 1 h or longer than 4 h.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenxian Li, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthes iology, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai Medical College of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>January 15, 2020</last_update_submitted>
  <last_update_submitted_qc>January 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>midazolam</keyword>
  <keyword>cough</keyword>
  <keyword>sedation</keyword>
  <keyword>pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

